LOXL1-AS1 depletion suppresses proliferation, migration, invasion, and angiogenesis of this type of cancer cells through downregulating Lysophospholipase 1 (LYPLA1), a direct target of miR-526b-5p (49). Here, LYPLA1 is linked to cancer.